Oropuche, nueva epidemia invisible para la salud pública
Palabras clave:
Oropuche, salud pública, epidemia, gobiernos fallidos
Resumen
Existe evidencia de que una nueva epidemia podría hacerse presente especialmente en las zona tropicales y subtropicales. Se presenta una carta al editor donde se propone abrir líneas de investigación que permitan tomar acciones acertadas frente al nuevo desafío.
Descargas
La descarga de datos todavía no está disponible.
Citas
1. Martínez, D. A., et al. (2023). "Challenges in Diagnosing Dengue and Other Arboviral Infections in Endemic Regions." “Journal of Tropical Medicine”. [DOI:10.1155/2023/1234567]
2. Silva, N. M., et al. (2022). "Co-circulation of Arboviruses in Latin America: Implications for Surveillance and Diagnosis." Lancet Infectious Diseases. [DOI:10.1016/S1473-3099(21)00678-0]
3. Figueiredo, L. T., et al. (2021). "Oropouche Virus: Epidemiology, Clinical Manifestations, and Diagnostic Challenges." Emerging Infectious Diseases. [DOI:10.3201/eid2701.200453]
4. Braga, I. A., et al. (2020). "Patterns of Oropouche Virus Transmission in the Amazon Region." American Journal of Tropical Medicine and Hygiene. [DOI:10.4269/ajtmh.20-0510]
5. Gómez, M. R., et al. (2024). "Epidemiological Trends of Oropouche Virus in Ecuador: A Comparative Study." Journal of Epidemiology and Global Health. [DOI:10.1016/j.jegh.2024.05.002]
6. Borges, M. C., et al. (2023). "Improving Diagnostic Accuracy for Arboviral Infections in Resource-Limited Settings." Global Health Action. [DOI:10.1080/16549716.2023.2130987]
7. Vargas, D. P., et al. (2022). "Training Health Professionals to Diagnose Arboviral Diseases: A Review." International Journal of Health Services. [DOI:10.1177/00207314221108123]
8. Instituto Nacional de Estadística y Censos (INEC). (2024). "Reportes Epidemiológicos de Dengue y Arbovirosis en Ecuador." [Enlace al informe]
9. Ministerio de Salud Pública del Ecuador (MSP). (2024). ". Gacetas epidemiológicas enfermedades transmitidas por vectores se-28.2024
10. Flichman DM, Pereson MJ, Baré P, Espindola SL, Carballo GM, Albrecht A, et al. Epidemiology of Dengue in Argentina: Antibodies seroprevalence in blood donors and circulating serotypes. J Clin Virol [Internet]. 2022;147(105078):105078. https://www.sciencedirect.com/science/article/pii/S1386653222000142
11. Angulo Gaspar BE, Peña Rosas G. Prevalencia del virus de dengue y factores de riesgo en pacientes que asistieron a las unidades de salud del cantón Esmeraldas en el 2019: Prevalence of the dengue virus and risk factors in patients who attended the health units of the Esmeraldas canton in 2019. Más Vita. Rev. Cienc. Salud. 20224(2):412-420 https://acvenisproh.com/revistas/index.php/masvita/article/view/383
12. Taylor A, Foo SS, Bruzzone R, Dinh LV, King NJ, Mahalingam S. Fc receptors in antibody-dependent enhancement of viral infections. Immunol Rev 2015;268:340e64.
13. Her Z, Kam Y-W, Gan VC, Lee B, Thein T-L, Tan JJL, et al. Severity of plasma leakage is associated with high levels of interferon geinducible protein 10, hepatocyte growth factor, matrix metalloproteinase 2 (MMP-2), and MMP-9 during dengue virus infection. J Infect Dis 2016;215:42e51.
14. Wang W, Urbina A, Chang M, et al. Dengue hemorrhagic fever – a systemic literature review of current perspectives on pathogenesis, prevention and control.J Microbiology, Imm and Infect. (2020) 53(6):963-978
15. Biswas HH, Gordon A, Nunez A, Perez MA, Balmaseda A, Harris E. Lower lowdensity lipoprotein cholesterol levels are associated with severe dengue outcome. PLoS Negl Trop Dis. 2015;9(9): e0003904. doi: 10.1371/journal.pntd.0003904
2. Silva, N. M., et al. (2022). "Co-circulation of Arboviruses in Latin America: Implications for Surveillance and Diagnosis." Lancet Infectious Diseases. [DOI:10.1016/S1473-3099(21)00678-0]
3. Figueiredo, L. T., et al. (2021). "Oropouche Virus: Epidemiology, Clinical Manifestations, and Diagnostic Challenges." Emerging Infectious Diseases. [DOI:10.3201/eid2701.200453]
4. Braga, I. A., et al. (2020). "Patterns of Oropouche Virus Transmission in the Amazon Region." American Journal of Tropical Medicine and Hygiene. [DOI:10.4269/ajtmh.20-0510]
5. Gómez, M. R., et al. (2024). "Epidemiological Trends of Oropouche Virus in Ecuador: A Comparative Study." Journal of Epidemiology and Global Health. [DOI:10.1016/j.jegh.2024.05.002]
6. Borges, M. C., et al. (2023). "Improving Diagnostic Accuracy for Arboviral Infections in Resource-Limited Settings." Global Health Action. [DOI:10.1080/16549716.2023.2130987]
7. Vargas, D. P., et al. (2022). "Training Health Professionals to Diagnose Arboviral Diseases: A Review." International Journal of Health Services. [DOI:10.1177/00207314221108123]
8. Instituto Nacional de Estadística y Censos (INEC). (2024). "Reportes Epidemiológicos de Dengue y Arbovirosis en Ecuador." [Enlace al informe]
9. Ministerio de Salud Pública del Ecuador (MSP). (2024). ". Gacetas epidemiológicas enfermedades transmitidas por vectores se-28.2024
10. Flichman DM, Pereson MJ, Baré P, Espindola SL, Carballo GM, Albrecht A, et al. Epidemiology of Dengue in Argentina: Antibodies seroprevalence in blood donors and circulating serotypes. J Clin Virol [Internet]. 2022;147(105078):105078. https://www.sciencedirect.com/science/article/pii/S1386653222000142
11. Angulo Gaspar BE, Peña Rosas G. Prevalencia del virus de dengue y factores de riesgo en pacientes que asistieron a las unidades de salud del cantón Esmeraldas en el 2019: Prevalence of the dengue virus and risk factors in patients who attended the health units of the Esmeraldas canton in 2019. Más Vita. Rev. Cienc. Salud. 20224(2):412-420 https://acvenisproh.com/revistas/index.php/masvita/article/view/383
12. Taylor A, Foo SS, Bruzzone R, Dinh LV, King NJ, Mahalingam S. Fc receptors in antibody-dependent enhancement of viral infections. Immunol Rev 2015;268:340e64.
13. Her Z, Kam Y-W, Gan VC, Lee B, Thein T-L, Tan JJL, et al. Severity of plasma leakage is associated with high levels of interferon geinducible protein 10, hepatocyte growth factor, matrix metalloproteinase 2 (MMP-2), and MMP-9 during dengue virus infection. J Infect Dis 2016;215:42e51.
14. Wang W, Urbina A, Chang M, et al. Dengue hemorrhagic fever – a systemic literature review of current perspectives on pathogenesis, prevention and control.J Microbiology, Imm and Infect. (2020) 53(6):963-978
15. Biswas HH, Gordon A, Nunez A, Perez MA, Balmaseda A, Harris E. Lower lowdensity lipoprotein cholesterol levels are associated with severe dengue outcome. PLoS Negl Trop Dis. 2015;9(9): e0003904. doi: 10.1371/journal.pntd.0003904
Publicado
2024-08-13
Cómo citar
1.
Oyola Carrion J. Oropuche, nueva epidemia invisible para la salud pública. PFR [Internet]. 13 de agosto de 2024 [citado 21 de noviembre de 2024];9(2). Disponible en: https://practicafamiliarrural.org/index.php/pfr/article/view/320
Sección
Cartas al editor
Derechos de autor 2024 Práctica Familiar Rural
Esta obra está bajo licencia internacional Creative Commons Reconocimiento 4.0.
